prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
44431,1.76694110000e+16,98817020,321,Daxas 500microgram tablets (AstraZeneca UK Ltd),Roflumilast,500microgram,Tablet,Oral,Phosphodiesterase Type 4  (PDE4) Inhibitors,January 2011,18047001,,,,,,,,,0,3030300
44173,1.76747110000e+16,98815020,1950,Roflumilast 500microgram tablets,Roflumilast,500microgram,Tablet,Oral,Phosphodiesterase Type 4  (PDE4) Inhibitors,December 2010,18046001,,,,,,,,,0,3030300
75672,3.58131110000e+16,82231021,35,Roflumilast 250microgram tablets,Roflumilast,250microgram,Tablet,Oral,Phosphodiesterase Type 4  (PDE4) Inhibitors,April 2019,82231021,,,,,,,,,0,3030300
